Published in Cancer Weekly, November 15th, 1999
C.E. Klein and colleagues from the University of Illinois and the University of Chicago, Illinois, conducted a study to determine whether gender influences the disposition of irinotecan (CPT-11) in cancer patients. They presented their study, "Gender Differences in the Disposition of Irinotecan in Cancer Patients," at the 1999 Annual Meeting of the American Association for Pharmaceutical Scientists, held November 14-18, 1999, in New Orleans, Louisiana.
"Forty-five patients with solid tumors and lymphomas received...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.